Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Operating Income
Theravance Biopharma Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Operating Income
-$53.3m
|
CAGR 3-Years
44%
|
CAGR 5-Years
26%
|
CAGR 10-Years
10%
|
See Also
What is Theravance Biopharma Inc's Operating Income?
Operating Income
-53.3m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Operating Income amounts to -53.3m USD.
What is Theravance Biopharma Inc's Operating Income growth rate?
Operating Income CAGR 10Y
10%
Over the last year, the Operating Income growth was 33%. The average annual Operating Income growth rates for Theravance Biopharma Inc have been 44% over the past three years , 26% over the past five years , and 10% over the past ten years .